EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Acceptability and somatic mutations in cervicovaginal self‐sampling for early endometrial cancer detection in women with Lynch syndrome

Paula Peremiquel-Trillas, José Manuel Martínez, Sònia Paytubi, Jon Frias-Gomez, Beatriz Pelegrina, Fátima Marin, Yolanda Benavente, Raquel Ibáñez, Marc Barahona, Sergi Fernandez-Gonzalez, Laura Cárdenas, Anna Taltavull und 10 weitere

International Journal of Cancer · 2025

DOI: 10.1002/ijc.35368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cancer, 2025. Verfasst von Paula Peremiquel-Trillas und 21 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain. Hauptthemen laut MEDLINE: Endometrial Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Early Detection of Cancer, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fundación Científica Asociación Española Contra el Cáncer, Agencia Estatal de Investigación, Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

New molecular approaches are being developed to detect endometrial cancer using minimally invasive sampling methods. This study aims to evaluate the acceptability of self‐collected cervicovaginal samples among women with Lynch syndrome, a group at high risk for developing endometrial cancer. Participants collected cervicovaginal self‐samples and answered an at‐home acceptability questionnaire in a cross‐sectional study. Self‐samples from a subset of these women were analyzed for somatic mutations using next‐generation sequencing (NGS), targeting a panel of 47 genes. A total of 61 (88.4%) out of 69 eligible women participated in the study. The overall self‐sampling experience was rated good or very good ( N = 55, 90.2%). Most of the women were confident about correctly sampling ( N = 58, 95.1%), and most reported no or mild pain ( N = 56, 91.8%). During self‐sample collection, most women reported feeling calm and comfortable and experiencing safety, privacy, and normality. In a pilot study using a subset of 15 samples, five somatic variants were identified in four self‐samples (4/15, 26.7%) in ACVR2A , ARID1A, APC , and KMT2D . During follow‐up, three out of four women with variants detected in the self‐sample underwent prophylactic hysterectomy at a median of 9.1 months, while one out of four developed endometrial cancer after 3.9 years since the collection of the sample. Self‐sampling is well‐accepted and well‐tolerated in women with Lynch syndrome and could potentially reduce some barriers associated with gynaecological surveillance. Further research is needed to evaluate the feasibility of implementing cervicovaginal self‐collection and the accuracy of molecular testing for gynaecological surveillance in women with Lynch syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Endometrial NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisEarly Detection of CancerMutationSpecimen HandlingHumansFemaleMiddle AgedCross-Sectional StudiesAdultPilot ProjectsHigh-Throughput Nucleotide SequencingAgedVaginaSurveys and Questionnaires

Stichwörter der Autor:innen

Lynch syndromeacceptabilityendometrial cancergynaecologic surveillanceself‐sampling

Autor:innen und Institutionen

  • Cancer Epidemiology Research Programme, Catalan Institute of Oncology. L'Hospitalet de Llobregat, Barcelona, Spain.
  • Bellvitge Biomedical Research Institute - IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain.
  • Faculty of Medicine, University of Barcelona, Barcelona, Spain.
  • Consortium for Biomedical Research in Epidemiology and Public Health-CIBERESP, Carlos III Institute of Health, Madrid, Spain.
  • Department of Gynaecology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Barcelona, Spain.
  • Consortium for Biomedical Research in Cancer-CIBERONC, Carlos III Institute of Health. Madrid, Spain.

ORCID-Profile: Martin Widschwendter, Xavier Matias-Guiu

Förderung

  • Fundación Científica Asociación Española Contra el Cáncer
  • Agencia Estatal de Investigación
  • Instituto de Salud Carlos III
  • Centro de Investigación Biomédica en Red de Cáncer
  • Agency for Management of University and Research Grants of the Generalitat de Catalunya (AGAUR)
  • Agència de Gestió d'Ajuts Universitaris i de Recerca

Zitieren

APA

Peremiquel-Trillas, P., Martínez, J. M., Paytubi, S., Frias-Gomez, J., Pelegrina, B., Marin, F., Benavente, Y., Ibáñez, R., Barahona, M., Fernandez-Gonzalez, S., Cárdenas, L., Taltavull, A., Darder, E., de Sanjosé, S., Widschwendter, M., Matias-Guiu, X., Bosch, X., Pineda, M., Ponce, J., …, & Costas, L. (2025). Acceptability and somatic mutations in cervicovaginal self‐sampling for early endometrial cancer detection in women with Lynch syndrome. International Journal of Cancer. https://doi.org/10.1002/ijc.35368

Vancouver

Peremiquel-Trillas P, Martínez JM, Paytubi S, Frias-Gomez J, Pelegrina B, Marin F, et al. Acceptability and somatic mutations in cervicovaginal self‐sampling for early endometrial cancer detection in women with Lynch syndrome. International Journal of Cancer. 2025. doi:10.1002/ijc.35368

BibTeX
@article{PeremiquelTrillas2025,
  author = {Peremiquel-Trillas, Paula and Martínez, José Manuel and Paytubi, Sònia and Frias-Gomez, Jon and Pelegrina, Beatriz and Marin, Fátima and Benavente, Yolanda and Ibáñez, Raquel and Barahona, Marc and Fernandez-Gonzalez, Sergi and Cárdenas, Laura and Taltavull, Anna and Darder, Esther and de Sanjosé, Silvia and Widschwendter, Martin and Matias-Guiu, Xavier and Bosch, Xavier and Pineda, Marta and Ponce, Jordi and Brunet, Joan and Alemany, Laia and Costas, Laura},
  title = {Acceptability and somatic mutations in cervicovaginal self‐sampling for early endometrial cancer detection in women with Lynch syndrome},
  journal = {International Journal of Cancer},
  year = {2025},
  doi = {10.1002/ijc.35368}
}
Kostenlos starten →